Global Net Invested Capital vs Capital Surpluse Analysis
| GMRE Stock | USD 8.98 0.27 2.92% |
Global Medical financial indicator trend analysis is much more than just examining Global Medical REIT latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Global Medical REIT is a good investment. Please check the relationship between Global Medical Net Invested Capital and its Capital Surpluse accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Net Invested Capital vs Capital Surpluse
Net Invested Capital vs Capital Surpluse Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Global Medical REIT Net Invested Capital account and Capital Surpluse. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Global Medical's Net Invested Capital and Capital Surpluse is 0.94. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Global Medical REIT, assuming nothing else is changed. The correlation between historical values of Global Medical's Net Invested Capital and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Global Medical REIT are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Net Invested Capital i.e., Global Medical's Net Invested Capital and Capital Surpluse go up and down completely randomly.
Correlation Coefficient | 0.94 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Capital Surpluse
Most indicators from Global Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Global Medical REIT current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. The current year's Enterprise Value is expected to grow to about 18.9 M, whereas Selling General Administrative is forecasted to decline to about 10.9 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 115.9M | 137.3M | 156.7M | 164.5M | Depreciation And Amortization | 79.0M | 98.8M | 103.1M | 108.3M |
Global Medical fundamental ratios Correlations
Click cells to compare fundamentals
Global Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Global Medical fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 884.9M | 1.1B | 1.3B | 1.4B | 1.3B | 1.3B | |
| Other Current Liab | 12.7M | 12.5M | 15.7M | 11.4M | 601.1M | 631.1M | |
| Total Current Liabilities | 365.3M | 541.4M | 540.6M | 666.1M | 619.3M | 650.3M | |
| Total Stockholder Equity | 430.3M | 444.8M | 622.8M | 633.0M | 583.6M | 612.8M | |
| Net Debt | 383.4M | 581.1M | 564.5M | 690.1M | 616.8M | 647.6M | |
| Retained Earnings | (71.4M) | (116.8M) | (157.0M) | (198.7M) | (239.0M) | (227.0M) | |
| Cash | 2.8M | 5.5M | 7.2M | 4.0M | 7.4M | 5.5M | |
| Cash And Short Term Investments | 2.8M | 5.5M | 7.2M | 4.0M | 7.4M | 5.5M | |
| Common Stock Total Equity | 44K | 49K | 65K | 66K | 75.9K | 79.7K | |
| Liabilities And Stockholders Equity | 884.9M | 1.1B | 1.3B | 1.4B | 1.3B | 1.3B | |
| Other Current Assets | (29.8M) | (41.5M) | (50.3M) | 18.3M | (41.1M) | (39.1M) | |
| Other Stockholder Equity | 433.3M | 504.8M | 711.4M | 722.0M | 722.4M | 758.5M | |
| Total Liab | 424.6M | 643.1M | 625.9M | 744.2M | 661.9M | 695.0M | |
| Total Current Assets | 15.6M | 21.3M | 24.9M | 30.5M | 14.4M | 13.4M | |
| Common Stock | 44K | 49K | 65K | 66K | 75.9K | 79.7K | |
| Common Stock Shares Outstanding | 33.9M | 46.3M | 60.6M | 65.5M | 65.6M | 68.8M | |
| Net Tangible Assets | 313.9M | 363.9M | 541.9M | 552.1M | 634.9M | 666.7M | |
| Accounts Payable | 5.1M | 7.3M | 10.3M | 13.8M | 12.8M | 13.4M | |
| Retained Earnings Total Equity | (71.4M) | (116.8M) | (157.0M) | (198.7M) | (178.8M) | (169.9M) | |
| Capital Surpluse | 433.3M | 504.8M | 711.4M | 722.0M | 830.3M | 871.8M | |
| Short Long Term Debt Total | 733.7M | 604.7M | 579.5M | 694.1M | 624.2M | 479.4M | |
| Other Liab | 11.2M | 12.6M | 20.4M | 17.5M | 20.1M | 21.1M | |
| Property Plant And Equipment Net | 3.1M | 3.6M | 3.8M | 3.5M | 7.6M | 7.2M | |
| Non Current Assets Total | 869.3M | 1.1B | 1.2B | 1.4B | 1.3B | 789.5M | |
| Non Currrent Assets Other | 793.5M | 971.9M | 1.1B | 1.2B | 8.5M | 8.0M | |
| Other Assets | 18.2M | 985.7M | 1.1B | 1.2B | (1K) | (950.0) | |
| Long Term Debt | 386.2M | 83.0M | 57.2M | 57.7M | 25.9M | 24.6M | |
| Net Receivables | 5.0M | 5.7M | 6.2M | 8.2M | 33.7M | 35.4M | |
| Long Term Debt Total | 386.2M | 83.0M | 65.0M | 57.7M | 66.3M | 63.0M | |
| Non Current Liabilities Total | 59.3M | 101.8M | 85.3M | 78.1M | 42.5M | 63.9M | |
| Property Plant And Equipment Gross | 3.1M | 3.6M | 3.8M | 3.5M | 11.0M | 21.6M | |
| Short Long Term Debt | 6.5M | 521.6M | 514.6M | 636.4M | 585.3M | 614.6M | |
| Accumulated Other Comprehensive Income | (6.7M) | (18.2M) | (6.6M) | 34.7M | 25.1M | 26.4M | |
| Non Current Liabilities Other | 11.9M | 14.4M | 12.2M | 15.0M | 9.0M | 8.1M | |
| Short Term Debt | 347.5M | 521.6M | 514.6M | 636.4M | 405K | 384.8K | |
| Property Plant Equipment | 793.0M | 1.0B | 1.2B | 1.3B | 1.5B | 1.6B | |
| Noncontrolling Interest In Consolidated Entity | 30.1M | 13.0M | 14.8M | 16.1M | 18.5M | 16.1M | |
| Good Will | 29.3M | 36.3M | 59.1M | 5.9M | 5.3M | 5.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Global Medical REIT is a strong investment it is important to analyze Global Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global Medical's future performance. For an informed investment choice regarding Global Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Dividend Share 0.21 | Revenue Per Share 2.082 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0171 |
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.